ArticleCardiovascular diabetology2024

Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies.

Loni Berkowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.